Jan 24, 2013 (SmarTrend(R) News Watch via COMTEX) --
Below are the three companies in the Biotechnology industry with the lowest forward earnings yields. Using projected earnings for the current fiscal year, the forward earnings yield is useful to compare a stock's return vs. owning a similar stock or other yield assets (e.g. bonds). Generally, the higher the earnings yield, the more undervalued the stock.Ligand Pharmaceuticals ranks lowest with a forward earnings yield of 0.2%. Cepheid is next with a forward earnings yield of 0.2%. Genomic Health ranks third lowest with a forward earnings yield of 0.7%.

Pharmacyclics follows with a forward earnings yield of 1.2%, and Alexion Pharmaceuticals rounds out the bottom five with a forward earnings yield of 2.2%.

SmarTrend recommended that subscribers consider buying shares of Alexion Pharmaceuticals on November 21st, 2012 as our technology indicated a new Uptrend was in progress when shares hit $93.88. Since that recommendation, shares of Alexion Pharmaceuticals have risen 3.7%. We continue to monitor Alexion Pharmaceuticals for any potential shift so investors can protect gains and will alert SmarTrend subscribers immediately.

Write to Chip Brian at cbrian@mysmartrend.com
---------------------------------------------------------------------------------------------
SmarTrend analyzes over 5,000 securities simultaneously throughout the trading day and provides its subscribers with trend change alerts in real time. To get a free trial of our trading calls and maximize your trading results, please visit http://www.MySmarTrend.com
Get exclusive, actionable insight into how the market is expected to trend prior to market open with our free morning newsletter. Sign up at: http://www.MySmarTrend.com/signup